We are live on ! Find out more
SGNT

SAGENT PHARMACEUTICALS INC COM STK (DE)
SGNT

Delisted

SGNT was delisted on the 29th of August, 2016.

Back to rankings

136 hedge funds and large institutions have $604M invested in SAGENT PHARMACEUTICALS INC COM STK (DE) in 2015 Q2 according to their latest regulatory filings, with 27 funds opening new positions, 62 increasing their positions, 35 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

77% more repeat investments, than reductions

Existing positions increased: 62 | Existing positions reduced: 35

50% more first-time investments, than exits

New positions opened: 27 | Existing positions closed: 18

7% more funds holding

Funds holding: 127 → 136 (+9)

5% more capital invested

Capital invested by funds: $576M → $604M (+$27.3M)

Holders
136
Holders Change
+9
Holders Change %
+7.09%
% of All Funds
3.66%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
27
Increased
62
Reduced
35
Closed
18
Calls
$10K
Puts
–
Net Calls
+$10K
Net Calls Change
+$9K

Top Buyers

Rank Fund Capital Flow
1
HM
HealthCor Management
New York
+$21.9M
2
PCM
Penn Capital Management
Pennsylvania
+$9.28M
3
Point72 Asset Management
Point72 Asset Management
Connecticut
+$5.87M
4
SFM
Soros Fund Management
New York
+$5.55M
5
Franklin Resources
Franklin Resources
California
+$4.42M

Top Sellers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
-$41.4M
2
SAM
Sectoral Asset Management
Quebec, Canada
-$16.9M
3
PAMU
Pictet Asset Management (UK)
United Kingdom
-$15.3M
4
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$3.34M
5
BAMS
Bellevue Asset Management (Switzerland)
Switzerland
-$2.33M
Name Holding Trade Value Shares
Change 		Change in
Stake
GC
51
Guggenheim Capital
Illinois
$1.95M +$1.92M +80,226 New
TCIM
52
TIAA CREF Investment Management
New York
$1.94M -$46.5K -1,941 -2%
SIM
53
Spark Investment Management
New York
$1.93M -$407K -17,000 -18%
CCMH
54
Cornerstone Capital Management Holdings
New York
$1.9M +$798K +33,300 +74%
Citadel Advisors
55
Citadel Advisors
Florida
$1.88M -$2.28M -95,106 -55%
Invesco
56
Invesco
Georgia
$1.86M -$1.29M -53,902 -41%
California Public Employees Retirement System
57
California Public Employees Retirement System
California
$1.86M +$568K +23,700 +45%
PAMU
58
Pictet Asset Management (UK)
United Kingdom
$1.65M -$15.3M -637,114 -90%
Two Sigma Investments
59
Two Sigma Investments
New York
$1.62M +$1.59M +66,570 New
Canada Life
60
Canada Life
Manitoba, Canada
$1.41M -$371K -15,500 -21%
ARTA
61
A.R.T. Advisors
New York
$1.35M +$403K +16,804 +43%
Asset Management One
62
Asset Management One
Japan
$1.34M – – –
Prudential Financial
63
Prudential Financial
New Jersey
$1.25M +$14.4K +600 +1%
CS
64
Credit Suisse
Switzerland
$1.18M +$235K +9,816 +25%
Comerica Bank
65
Comerica Bank
Texas
$1.11M +$555K +23,151 +103%
CIP
66
Convergence Investment Partners
Florida
$1.11M -$359K -15,002 -25%
Morgan Stanley
67
Morgan Stanley
New York
$1.11M -$41.4M -1,726,347 -97%
California State Teachers Retirement System (CalSTRS)
68
California State Teachers Retirement System (CalSTRS)
California
$983K +$11.8K +493 +1%
QI
69
QS Investors
New York
$980K -$91K -3,800 -9%
VOYA Investment Management
70
VOYA Investment Management
Georgia
$919K – – –
BG
71
BlackRock Group
United Kingdom
$913K +$226K +9,414 +33%
AllianceBernstein
72
AllianceBernstein
Tennessee
$873K +$86.2K +3,600 +11%
Public Sector Pension Investment Board (PSP Investments)
73
Public Sector Pension Investment Board (PSP Investments)
Quebec, Canada
$855K -$180K -7,500 -18%
MC
74
Menta Capital
California
$800K +$788K +32,889 New
TI
75
Trexquant Investment
Connecticut
$763K +$752K +31,400 New
1 2
3
4 5

SGNT Hedge Fund Activity: Q2 2015 in Review

136 of the 3,712 institutional investors tracked by Wall St. Rank reported a position in SAGENT PHARMACEUTICALS INC COM STK (DE) (SGNT) for Q2 2015, worth a combined $604M — up 4.7% from $576M a quarter earlier.

Buyers outnumbered sellers: 27 funds opened new SGNT positions and 18 closed out — a net gain of 9 holders — while 62 added to existing stakes and 35 trimmed.

The largest buyer was HealthCor Management, opening a new position worth an estimated $21.9M. The largest seller was Morgan Stanley, cutting an estimated $41.4M.

  • 136 institutional investors held SAGENT PHARMACEUTICALS INC COM STK (DE) (SGNT) as of Q2 2015, up from 127 in Q1 2015.
  • Funds reported $604M of SAGENT PHARMACEUTICALS INC COM STK (DE) stock for Q2 2015, up 4.7% quarter-over-quarter.
  • 27 funds opened new SAGENT PHARMACEUTICALS INC COM STK (DE) positions in Q2 2015 and 18 closed out, a net change of +9 holders.
  • The largest SAGENT PHARMACEUTICALS INC COM STK (DE) buyer in Q2 2015 was HealthCor Management, an estimated $21.9M added.
  • The largest SAGENT PHARMACEUTICALS INC COM STK (DE) seller in Q2 2015 was Morgan Stanley, an estimated $41.4M sold.

Based on aggregated 13F filings for Q2 2015.